On 2025-05-14, Foghorn Therapeutics Inc. (FHTX) announced earnings per share of $-0.30 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.30.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.31 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-14 | 2025-03-31 | $-0.30 | $-0.30 |
2025-03-06 | 2024-12-31 | $-0.29 | $-0.30 |
2024-11-04 | 2024-09-30 | $-0.42 | $-0.31 |
2024-08-08 | 2024-06-30 | $-0.60 | $-0.45 |
2024-05-06 | 2024-03-31 | $-0.55 | $-0.59 |
2024-03-07 | 2023-12-31 | $-0.79 | $-0.57 |
2023-11-02 | 2023-09-30 | $-0.72 | $-0.34 |
2023-08-04 | 2023-06-30 | $-0.73 | $-0.70 |
2023-05-08 | 2023-03-31 | $-0.68 | $-0.73 |
2023-03-09 | 2022-12-31 | $-0.59 | $-0.69 |
2022-11-08 | 2022-09-30 | $-0.60 | $-0.62 |
2022-08-09 | 2022-06-30 | $-0.53 | $-0.66 |
2022-05-09 | 2022-03-31 | $-0.40 | $-0.65 |
2022-03-10 | 2021-12-31 | $-0.74 | $-0.77 |
2021-11-09 | 2021-09-30 | $-0.66 | $-0.71 |
2021-08-10 | 2021-06-30 | $-0.63 | $-0.63 |
2021-05-11 | 2021-03-31 | -- | $-0.62 |
2020-12-04 | 2020-09-30 | $-2.12 | $-3.12 |